David Pérol
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 72
- Cancer Treatment and Pharmacology 12
- Cancer Immunotherapy and Biomarkers 11
- Cancer survivorship and care 11
-
- Lung Cancer Treatments and Mutations 14
- Sarcoma Diagnosis and Treatment 13
- Renal cell carcinoma treatment 12
- Co-authors
- Jean‐Yves Blay (52 shared papers)Sylvie Chabaud (45 shared papers)Isabelle L. Ray-Coquard (34 shared papers)Christine Chevreau (13 shared papers)Axel Le Cesne (16 shared papers)Sylvie Négrier (18 shared papers)Bernard J. Escudier (10 shared papers)Thomas Bachelot (34 shared papers)
- Journals
- Annals of Oncology (36 papers)European Journal of Cancer (20 papers)International Journal of Radiation Oncology*Biology*Physics (10 papers)BMC Cancer (10 papers)Journal of Clinical Oncology (8 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
David Pérol
218 papers receiving 9.0k citations
David Pérol's Hit Papers
Peers
Comparison fields: 5 of 147
- Gastroenterology 847
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 3.0k
- Reproductive Medicine 644
- Cancer Research 973
Countries citing papers authored by David Pérol
This map shows the geographic impact of David Pérol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Pérol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Pérol more than expected).
Fields of papers citing papers by David Pérol
This network shows the impact of papers produced by David Pérol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Pérol. The network helps show where David Pérol may publish in the future.
Co-authors
The 25 scholars most cited alongside David Pérol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 236 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer Hit paper breakdown → | 2019 | 1510 |
| 2 | Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas Hit paper breakdown → | 2009 | 659 |
| 3 | 2007 | 323 | |
| 4 | 2002 | 298 | |
| 5 | 2007 | 257 | |
| 6 | 2019 | 249 | |
| 7 | 2005 | 237 | |
| 8 | 2010 | 232 | |
| 9 | 2018 | 220 | |
| 10 | 2011 | 197 | |
| 11 | 2010 | 189 | |
| 12 | 2012 | 186 | |
| 13 | 2004 | 174 | |
| 14 | 2004 | 153 | |
| 15 | 2019 | 148 | |
| 16 | 2007 | 147 | |
| 17 | 2016 | 132 | |
| 18 | 2005 | 129 | |
| 19 | 2007 | 120 | |
| 20 | 2011 | 117 |
About David Pérol
David Pérol is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Gastroenterology, Cancer Research and Otorhinolaryngology, having authored 236 papers that have together received 9.3k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (16 papers), Cancer Genomics and Diagnostics (16 papers), Lung Cancer Treatments and Mutations (14 papers), Sarcoma Diagnosis and Treatment (13 papers), Cancer Treatment and Pharmacology (12 papers), Renal cell carcinoma treatment (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Cancer survivorship and care (11 papers). The work is most often cited by research in Gastroenterology (847 citations), Oncology (3.3k citations), Pulmonary and Respiratory Medicine (3.0k citations), Reproductive Medicine (644 citations) and Cancer Research (973 citations). David Pérol has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Yves Blay, Sylvie Chabaud, Isabelle L. Ray-Coquard, Christine Chevreau, Axel Le Cesne, Sylvie Négrier, Bernard J. Escudier, Thomas Bachelot, C. Carrié and Alain Ravaud. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, BMC Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.